Epidemiology of cardiovascular disease in chronic renal disease

R N Foley1, P S Parfrey, M J Sarnak

  • 1Division of Nephrology and Clinical Epidemiology, Memorial University of Newfoundland, Canada.

Insights

Patients with chronic kidney disease (CKD) face significantly higher cardiovascular disease risks. CKD patients exhibit elevated rates of coronary artery disease, left ventricular hypertrophy, and cardiac failure, leading to substantially increased mortality.

Area of Science:

  • Nephrology
  • Cardiology
  • Public Health

Background:

  • Patients with chronic renal disease (CRD) exhibit a markedly elevated risk of cardiovascular disease (CVD) compared to the general population.
  • Prevalence rates for coronary artery disease (CAD) and left ventricular hypertrophy (LVH) are substantial in CRD patients undergoing dialysis.
  • Cardiovascular mortality is disproportionately high in CRD patients, even after adjusting for demographic and clinical factors.

Purpose of the Study:

  • To highlight the significantly increased cardiovascular disease burden in patients with chronic renal disease.
  • To emphasize the high prevalence of specific cardiovascular conditions and mortality rates within this patient group.
  • To underscore the importance of considering CRD patients as a high-risk group for cardiovascular events.

Main Methods:

  • The study synthesizes existing data and epidemiological findings on cardiovascular disease prevalence and mortality in chronic renal disease populations.
  • Analysis includes data from patients undergoing hemodialysis and peritoneal dialysis.
  • Risk factors such as age, gender, race, and diabetes status were considered in risk stratification.

Main Results:

  • Approximately 40% of dialysis patients have coronary artery disease, and 75% have left ventricular hypertrophy.
  • Cardiovascular mortality in dialysis patients is 10 to 20 times higher than in the general population.
  • Cardiac failure affects about 40% of hemodialysis and peritoneal dialysis patients and is an independent predictor of death.

Conclusions:

  • Chronic renal disease patients represent a highest-risk group for cardiovascular events.
  • Cardiac failure is prevalent in CRD and linked to underlying CAD and LVH, posing a significant mortality risk.
  • Clinical evaluation for cardiovascular disease is crucial in CRD patients presenting with cardiac failure symptoms.

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...